FONAR Corp (FONR)
NASDAQHealth CareMedical - Equipment & ServicesSnapshot 2026-09-04
$19.090.00%
Close 2026-06-05 · 1-day change
NASDAQHealth CareMedical - Equipment & ServicesSnapshot 2026-09-04
QuarterlyIQ Insights · FONR
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||
| Revenues | 105.3 | 104.4 | 102.9 | 98.6 | 97.6 | 89.9 | 85.7 | 87.2 | 81.5 | 78.0 | 2.1 | 2.0 | 2.0 | 1.2 | 0.8 |
| Total Revenues | 105.3 | 104.4 | 102.9 | 98.6 | 97.6 | 89.9 | 85.7 | 87.2 | 81.5 | 78.0 | 2.1 | 2.0 | 2.0 | 1.2 | 0.8 |
| Operating Expenses & Income | |||||||||||||||
| Selling, General & Admin | 31.1 | 29.7 | 26.9 | 29.4 | 23.5 | 24.7 | 26.7 | 19.3 | 18.1 | 19.4 | 18.5 | 17.4 | 18.6 | 12.5 | 8.7 |
| R&D Expenses | 1.8 | 1.6 | 1.7 | 1.6 | 1.5 | 1.6 | 2.0 | 1.8 | 1.8 | 1.5 | 1.6 | 1.8 | 1.8 | 1.4 | 1.2 |
| Other Operating Expenses, Total | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.0 |
| Operating Income | — | — | 4.5 | 11.1 | 5.3 | (7.1) | 14.1 | 22.5 | 19.8 | 19.3 | 14.5 | 12.8 | 11.0 | 8.0 | 7.0 |
| Earnings from Continuing Operations | |||||||||||||||
| Interest Expense | — | 0.0 | 0.1 | 0.1 | 0.3 | 0.2 | 0.1 | 0.1 | (0.2) | 0.0 | (0.3) | (0.7) | (0.9) | (0.5) | 0.5 |
| Asset Writedown | — | — | — | — | — | — | — | — | — | — | — | — | 0.4 | 0.4 | — |
| EBT, Incl. Unusual Items | 11.4 | 13.8 | 19.3 | 15.8 | 22.8 | 17.7 | 14.1 | 22.5 | 19.8 | 19.3 | 14.5 | 12.8 | 11.0 | 8.0 | 7.0 |
| Income Tax Expense | 2.5 | 3.1 | 5.2 | 3.6 | 5.5 | 4.0 | 2.4 | 2.0 | (5.7) | (4.4) | (4.3) | 2.6 | (2.3) | 2.3 | 0.1 |
| Net Income | |||||||||||||||
| Minority Interest | 2.2 | 2.3 | 3.5 | 2.8 | 4.8 | 3.5 | 3.5 | 5.2 | (4.2) | (4.1) | (3.1) | (2.5) | (3.0) | (1.6) | 1.1 |
| Net Income | 6.7 | 8.3 | 10.6 | 9.4 | 12.4 | 10.2 | 8.2 | 15.3 | 21.2 | 19.6 | 15.7 | 12.9 | 10.4 | 8.7 | 5.8 |
| Per Share | |||||||||||||||
| Basic EPS | 0.97 | — | — | — | 1.78 | 1.47 | 1.28 | — | — | — | 2.60 | 2.13 | — | 1.46 | 1.00 |
| Basic Weighted Avg Shares | 6.9 | — | — | — | 6.6 | 6.5 | 6.4 | — | — | — | 6.1 | 6.1 | 6.0 | 5.9 | 5.8 |
| Diluted Weighted Avg Shares | — | — | — | — | 6.7 | 6.6 | — | — | — | — | — | — | 6.1 | — | — |
| Supplemental | |||||||||||||||
| EBITDA | — | — | 9.1 | 15.7 | 9.8 | (3.0) | 18.1 | 26.4 | 23.7 | 22.8 | 17.8 | 16.4 | 14.9 | 10.4 | 9.2 |
| EBIT | — | — | 4.5 | 11.1 | 5.3 | (7.1) | 14.1 | 22.5 | 19.8 | 19.3 | 14.5 | 12.8 | 11.0 | 8.0 | 7.0 |
| Effective Tax Rate | 21.9% | — | — | 23.0% | 24.3% | 22.6% | 17.3% | 8.9% | -28.7% | -22.6% | -29.6% | 20.4% | -21.3% | 28.6% | 2.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.